PNPLA2
PNPLA2 (patatin like domain 2, triacylglycerol lipase) is a lipase that catalyses the first step of triglyceride hydrolysis in lipid droplets. It is also known as desnutrin, ATGL, TTS-2.2, FP17548 and iPLA2zeta. Browse Assay Genie's current range of PNPLA2 research reagents below, or read on for the biology behind the target.
PNPLA2 catalyses the initial step in triglyceride hydrolysis in the lipid droplets of adipocytes and non-adipocytes. It shows a strong preference for long-chain fatty acid esters at the sn-2 position of the glycerol backbone and acts coordinately with LIPE/HLS and DGAT2 within the lipolytic cascade. Beyond its lipase activity, it has acylglycerol transacylase and phospholipase A2 activities. It can transfer fatty acid from triglyceride to retinol, hydrolyse retinylesters and generate 1,3-diacylglycerol from triglycerides.
The enzyme also regulates adiposome size and may contribute to adiposome degradation. In adipocytes it catalyses formation of an ester bond between hydroxy fatty acids and fatty acids derived from triglycerides or diglycerides, producing fatty acid esters of hydroxy fatty acids (FAHFAs). It acts antagonistically with LDAH in regulating cellular lipid stores and inhibits LDAH-stimulated lipid droplet fusion. PNPLA2 may be important in energy homeostasis and in the response to starvation, where enhanced triglyceride hydrolysis supplies free fatty acids to other tissues for oxidation during energy depletion.
The PNPLA2 gene belongs to the HGNC groups of lipases and patatin like phospholipase domain containing proteins. The protein localises to lipid droplets, the cell membrane and the cytoplasm. Mutations in the gene are associated with neutral lipid storage disease with myopathy. Mouse and rat orthologs are both named Pnpla2, and the protein is also referred to by its previous name, patatin-like phospholipase domain containing 2.
PNPLA2 catalyses the first step of triglyceride hydrolysis and works with LIPE/HLS and DGAT2 in the lipolytic cascade.
The enzyme regulates adiposome size and opposes LDAH, inhibiting LDAH-stimulated lipid droplet fusion and shaping cellular lipid stores.
PNPLA2 may supply free fatty acids to other tissues for oxidation during energy depletion, making it relevant to energy balance studies.
Mutations in the PNPLA2 gene are associated with neutral lipid storage disease with myopathy, linking the enzyme to lipid storage disorders.
PNPLA2 catalyses the first step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets. It prefers long-chain fatty acid esters at the sn-2 position and acts with LIPE/HLS and DGAT2. It also has acylglycerol transacylase and phospholipase A2 activities.
PNPLA2 is also called desnutrin, ATGL, TTS-2.2, FP17548 and iPLA2zeta. The UniProt protein name is patatin-like phospholipase domain-containing protein 2, and the HGNC full name is patatin like domain 2, triacylglycerol lipase.
Mutations in the PNPLA2 gene are associated with neutral lipid storage disease with myopathy. Mouse and rat both carry a Pnpla2 ortholog; check the datasheet of any product for its validated reactivity.
Other patatin-like phospholipase domain-containing proteins and lipid metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96AD5; product specifications from Assay Genie datasheets.